Design, synthesis and structure–activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents
Authors:
- Ahmad M. FaragAFAhmad M. Farag
- Korany A.K. AliKAKorany A.K. Ali
- Taha M.A. El-DebssTETaha M.A. El-Debss
- Abdelrahman S. MayhoubAMAbdelrahman S. Mayhoub
- Abdel-Galil E. AmrAAAbdel-Galil E. Amr
- Naglaa A. Abdel-HafezNANaglaa A. Abdel-Hafez
- Mohamed M. AbdullaMAMohamed M. Abdulla
- 1 December 2010
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 45 (12) , 5887-5898
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Synthesis and Structure‐Activity Relationship Studies of Pyrazole‐based Heterocycles as Antitumor AgentsArchiv der Pharmazie, 2010
- Synthesis of bipyrazole and 1,3,4-thiadiazole derivativesJournal of Chemical Research, 2009
- Synthesis of new 3-pyridinecarboxylates of potential vasodilation propertiesEuropean Journal of Medicinal Chemistry, 2008
- Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancerCancer Letters, 2008
- A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancerEuropean Journal of Cancer, 2006
- Cannabinoid derivatives induce cell death in pancreatic MIA PaCa‐2 cells via a receptor‐independent mechanismFEBS Letters, 2006
- A Phase II Trial of Irinotecan, 5-Fluorouracil and Leucovorin Combined with Celecoxib and Glutamine as First-Line Therapy for Advanced Colorectal CancerOncology, 2005
- Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based TreatmentsClinical Cancer Research, 2004
- LetrozoleDrugs, 2004
- Aromatease, its inhibitors and their use in breast cancer treatmentPharmacology & Therapeutics, 1993